Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...
Hlavní autoři: | Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K |
---|---|
Médium: | Journal article |
Vydáno: |
American Society for Clinical Investigation
2019
|
Podobné jednotky
-
Diagnostic use of autoantibodies in myasthenia gravis.
Autor: Leite, M, a další
Vydáno: (2010) -
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
Autor: Miriam L. Fichtner, a další
Vydáno: (2022-10-01) -
Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
Autor: Gomez, A, a další
Vydáno: (2016) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
Autor: Miriam L Fichtner, a další
Vydáno: (2022-01-01) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
Autor: Miriam L. Fichtner, a další
Vydáno: (2022-01-01)